ÄûÃʵ¼º½

News

New statistical model effectively predicts the toxicity of pharmaceutical molecules

A statistical component model can be used to identify associations between chemicals and toxicological effects.
The component model describes statistical links between chemicals and the effect of their molecular toxins. Picture: Juuso Parkkinen, Aalto University.

The joint Aalto University, Karolinska Institute and Institute for Molecular Medicine Finland (FIMM) study included over 1,300 known pharmaceutical molecules, on which there is a wealth of measurement data available.

‘The study uses systematic data-driven analysis to combine toxicity measurements taken on cell lines with gene expression responses describing gene activation. Toxicity includes growth inhibitory and cell killing effects. The method developed in the study makes it possible to more accurately predict the toxicity of new molecules because it makes use of advanced statistical methods and much bigger datasets than before,’ explains Juuso Parkkinen, who completed his doctoral dissertation at Aalto University.

At present, toxicity is primarily measured by means of animal testing. Thanks to this new method, animal testing can be partly replaced in the future by a combination of cell line testing and statistical modelling. This would also result in considerable cost savings for pharmaceutical development.

‘The new prediction method can be applied to new pharmaceutical molecules and other chemicals currently in product development to eliminate possible toxic molecules,’ adds Parkkinen.

Advances in statistical machine learning and artificial intelligence methods have risen to play a crucial role in many application areas in addition to medical research.

‘Juuso Parkkinen is an excellent example of the usefulness of Aalto University's artificial intelligence research and doctoral studies: He wrote his dissertation on medicinal applications in my research group and then transferred to Reaktor to apply data science to a wide range of business needs,’ praises Parkkinen's dissertation adviser, Professor Samuel Kaski.

Pharmaceutical toxicity was studied by Juuso Parkkinen and Samuel Kaski of Aalto University, Pekka Kohonen, Egon Willighagen, Rebecca Ceder and Roland Grafström of Karoliska Institute and Krister Wennerberg of the Institute for Molecular Medicine Finland (FIMM).

Further information:                                         

Juuso Parkkinen
AI Designer and Senior Data Scientist
Reaktor
juuso.parkkinen@reaktor.fi
tel. +358 50 356 3916

Samuel Kaski
Professor
Aalto University
samuel.kaski@aalto.fi
tel. +358 50 305 8694

Journal article in Nature Communications:

  • Updated:
  • Published:
Share
URL copied!

Read more news

Four people standing in a spacious indoor area with signs above them. The floor is tiled and walls are white.
Appointments, Cooperation Published:

Hannu Martola appointed as Chair of the Aalto University Alumni Network Board

The board’s new members are Esa Arola, Eila Lindroos and Terttu Sopanen. Continuing members are Ari Bertula, Laura Nikola and Katja Soini.
A close-up of various electronic waste pieces, including circuit boards, wires, and metal fragments in different colours.
Research & Art Published:

VTT, Aalto University and GTK: How to ensure Finland captures the multi‑billion growth potential of mineral economy

Finland is rising to the forefront of the mineral economy through new research initiatives and closer collaboration
Viisi Aalto-yliopiston opiskelijoita pöydän äärellä
Cooperation, University Published:

Kielibuusti Project 2025–2028 Supports International Students and Staff at Aalto University

The Kielibuusti enhances opportunities for international students and staff to learn and use the Finnish language, and it supports the multilingual working practices within the Aalto community.
Speaker and attendees at Demo Day 2025 event
Campus Published:

A Grid in 2025: Record demand, new faces, and a calendar that brought the ecosystem together

More teams, more traction, and more touchpoints: A Grid’s 2025 affirmed Otaniemi’s place as a launchpad for ambitious founders.